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Background: The main objective is to evaluate the way to graft the dental pulp stem cells (DPSC) in periodontal 
defects that best regenerate periodontal tissues. Numerous procedures have been done to promote periodontal re-
generation. Bone grafts show good gains clinically and radiographically but histologically seem to have minimal 
osteoinductive capacity. Another option that exceeds conventional surgery in reducing probing depth and increa-
sing insertion is guided tissue regeneration and tissue engineering that could be an alternative approach to help in 
the regeneration of living functional bone and peri-dental structures.
Material and Methods: A search was carried out in Cochrane, PubMed-MEDLINE and Scopus databases with 
keywords: “dental pulp stem cells”, “periodontal regeneration”, “guided tissue regeneration, periodontal”, “tissue 
regeneration”, “periodontal bone defects”, “periodontal tissue engineering” and “periodontal defect”. Inclusion cri-
teria were articles in English, maximum 10 years old, in which DPSC were used to regenerate a periodontal defect. 
Exclusion criteria were studies not published in English, case reports, case series, literature reviews, and studies in 
which periodontal defect was caused by dental extraction.
Results: Out of the 185 articles identified, 101 after excluding duplicates, of which 94 were discarded when rea-
ding the title and abstract. 7 articles were obtained for the full text reading: a case report and a case series were 
eliminated. The systematic review is performed with 5 animal testing studies in vivo. The DPSC sheets regenerate a 
greater amount of bone than the injection. If HGF (hepatocyte growth factor) is added, the maximum bone volume 
regenerated (69.3 ± 3.9 mm3; p <0.01) is achieved. Similar results were obtained in all carriers tested except in the 
controls. The periodontal ligament stem cells (PDLSC) formed more new bone, compared to DPSC (p <0.001). The 
presence of new cementum and periodontal ligament induced by CMLPs, was detected histologically but DPSC 
cannot achieve it alone.
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Introduction
Periodontitis is one of the main causes of dental loss in 
adults (1). Non-surgical and surgical therapies are the basis 
of treatment, however the way to treat patients currently is 
different, due to the greater pathology understanding (2).
Numerous procedures have been done to promote pe-
riodontal regeneration. Bone grafts show good gains 
clinically and radiographically but histologically seem 
to have minimal osteoinductive capacity (3,4). Another 
option is guided tissue regeneration (GTR) that exceeds 
conventional surgery in reducing probing depth and in-
creasing insertion (5).
Tissue engineering (TE) could be considered an alterna-
tive approach and can help in the regeneration of living 
functional bone and peri-dental structures (4). The suc-
cess of periodontal TE requires: progenitor cells capable 
of differentiating into osteoblasts, cementoblasts and fi-
broblasts, appropriate signals to modulate cell differen-
tiation and tissue neogenesis, and a matrix to support it 
and facilitate these processes (6).
Dental pulp stem cells (DPSC) were the first identified 
human dental stem cells (7). Afterwards, stem cells were 
isolated from exfoliated temporal teeth, apical papilla 
and periodontal ligament (PDL) (6,8), that are capable 
to be differentiated in cementoblasts and osteoblasts 
(9,10). DPSCs are easily accessible in large number be-
cause can be obtained from extracted human teeth and 
the method of its obtention is non-invasive (11,12). It is 
even speculated that they can be also obtained from den-
tal pulp with inflammation (13) or from a carious tooth 
(14) being able to differentiate into osteoblast-like cells 
forming new bone (15-17). Recent studies carried out in 
animal models, consider DPSCs as a potential treatment 
for periodontal regeneration (4,18).
The author’s main objective is to evaluate which is 
the carrier that allow the best results when grafting the 
DPSCs to regenerate periodontal bone loss (not caused 
by the extraction of an adjacent tooth). The secondary 
objective is to analyse if the DPSCs are able to restore 
other periodontal tissues (PDL and cementum). To reach 
these objectives a PICO question was maid: In periodon-
tal bone loss defects, DPSCs grafted with a carrier have 
better results compared when no carrier is used in tissue 
engineering techniques?
Material and Methods
A search was carried out between October and Novem-
ber 2016 in the Cochrane, PubMed-MEDLINE and Sco-
Conclusions: Cementum or PDL regeneration does not depend only on DPSC but on other unknown factors. PDLSC 
has better periodontal regeneration than DPSC. DPSC significantly favours the regeneration of periodontal bone tissue 
but has few advantages over other grafts. It is necessary to study which growth factors or matrices can enhance their 
capacity for periodontal regeneration.
Key words: Dental pulp, stem cells, periodontal guided tissue regeneration, periodontal bone loss.
pus databases. The strategy in the search of articles was 
made using the keywords: “dental pulp stem cells” AND 
“periodontal regeneration”(MeSH term) and ((“Stem 
Cells”[Mesh]) AND “Dental Pulp”[Mesh]) AND “Gui-
ded Tissue Regeneration, Periodontal”[Mesh]. In Sco-
pus: “dental pulp stem cell” AND “tissue regeneration”, 
“periodontal bone defects” AND “dental pulp stem cell” 
AND “tissue regeneration”, “dental pulp stem cells” 
AND “periodontal regeneration”, “dental pulp stem 
cells” AND “tissue regeneration” AND “periodontal”, 
“dental pulp” AND “stem cells” AND “periodontal re-
generation”, “dental pulp” AND “stem cell” AND “pe-
riodontal tissue engineering” and “periodontal defect” 
AND “dental pulp stem cell”. These terms were also 
used without MeSH in PubMed-MEDLINE.
The quality of evidence evaluation was analysed by the 
OSTEBA (Health Technology Assessment Service of 
the Basque Government Health Department) template 
for case series and GRADE criteria for other studies 
(19).
Inclusion criteria were articles published in English wi-
thin the last ten years (from November 2006), in which 
DPSCs were used to regenerate a periodontal bone de-
fect not caused by the previous adjacent tooth extrac-
tion, in human and animal research studies that followed 
ARRIVE guide criteria of the National Center for the 
Replacement Refinement and Reduction of Animals in 
Research (NC3Rs) for evaluating the quality of animal 
research in experimental studies in vivo (20). The exclu-
sion criteria were studies not published in English, case 
reports, case series (less than ten) and literature reviews.
Results
Out of the 185 articles initially identified, 84 duplicates 
were discarded, obtaining a total of 101 articles scree-
ned, of these 94 articles, 88 were excluded after reading 
the title and abstract because did not exactly match with 
the subject to be reviewed; despite coinciding with the 
subject, 5 reviews and an article not written in English 
were rejected. We obtain 7 relevant articles for full text 
critical reading, 2 human studies and 5 animal studies. 
Human studies were evaluated using the OSTEBA tem-
plate for case series (18), and therefore, it was decided 
to discard them, since the level of evidence was low. Fi-
nally, it is decided to carry out a systematic review, as 
an update in preclinical research of 5 in vivo animal stu-
dies. Figure 1 shows PRISMA flow diagram (21). The 
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Fig. 1: PRISMA flow diagram (21).
included animal studies (22-26) follow the ARRIVE 
guideline criteria of the NC3Rs (20). Although one or 
two items were not specified, the articles were accepted 
for review (Table 1). Table 2, 2 continue summarizes the 
main data and the comparable results of the studies in-
cluded in the systematic review.
From the reviewed studies, three did not use a scaffold to 
graft the DPSC (22,24,26), whereas the remaining two 
	
ARRIVE guideline for animal research: 
reporting of in vivo experiments 
Item Cao et al., 
2015 (22) 
Gonçalves et 
al., 2016 (23) 
Hu et al., 
2016 (24) 
Khorsand et 
al., 2013 (25) 
Park et al., 
2011 (26) 
Title 1 Yes Yes Yes Yes Yes 
Abstract 2 Yes Yes Yes Yes Yes 
Background 3 Yes Yes Yes Yes Yes 
Objectives 4 Yes Yes Yes Yes Yes 
Ethical statement 5 Yes Yes Yes Yes Yes 
Study design 6 Yes Yes Yes Yes Yes 
Experimental procedures 7 Yes Yes Yes Yes Yes 
Experimental animals 8 Yes Yes Yes Yes Yes 
Housing and husbandry 9 Yes No No Yes Yes 
Sample size 10 Yes Yes Yes Yes Yes 
Allocating animals to experimental groups 11 Yes Yes Yes Yes Yes 
Experimental outcomes 12 Yes Yes Yes Yes Yes 
Statistical methods 13 Yes Yes Yes Yes Yes 
Baseline data 14 Yes Yes Yes Yes Yes 
Numbers analysed 15 Yes Yes Yes Yes Yes 
Outcomes and estimation 16 Yes Yes Yes Yes Yes 
Adverse events 17 No AE No AE No AE No AE No AE 
Interpretation / scientific implications 18 Yes Yes Yes Yes Yes 
Generalisability / translation 19 Yes Yes Yes Yes Yes 
Funding 20 No Yes No No Yes 
Table 1: Application of the NC3Rs ARRIVE guideline. NoAE; no adverse events (20).
used PLLA/COL/HA, PisPLLA/COL/HA (23) or Bio-
Oss® (25) as scaffolds.
All studies take the same experimental defect of three 
bone walls and a fourth dental wall, except Gonçalves et 
al. (23) in which the defect is a bone fenestration with 
dental involvement.
In general, a significant increase in bone production was 
observed in the experimental groups (with DPSC), com-
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































pared to the control groups in which no treatment was 
performed.
Cao et al. (22) study, used miniature pigs to create perio-
dontal bony defects in the upper and lower first molars 
comparing the use of DPSC from human impacted third 
molars in sheets or injected, and with and without addi-
tion of hepatocyte growth factor (HGF). Grafting stem 
cells as sheets showed a higher amount of new bone at 
12 weeks (p <0.01) compared to dissociated cells (DPSC 
injection). Hu et al. (24) with the same model obtained 
similar results. The volume of regenerated bone in the 
group of DPSC sheets (52.7 ± 4.1 mm3) was significant-
ly higher than in the injection group (32.4 ± 5.1 mm3) 
(p <0.05).
In contrast, in Khorsand et al. (25) used 20 dogs to 
create a three-walled surgical defect to compare a Bio-
Oss® xenograft scaffold alone or with DPSC from upper 
premolar. Histomorphometric analysis showed that the 
amount of cementum and PDL regenerated in the DPSC 
+ Bio-Oss® group was significantly higher than the con-
trol (2.42 ± 1.40 mm and 1.77 ± 1.27 mm, respectively, 
p <0.05) (25).
In Gonçalves et al. (23) research, were used rats with 30 
periodontal fenestration defects located in the first molar 
buccal root. Five experimental groups were evaluated, 
depending on the scaffold: poly(L-lactide), collagen 
and hydroxyapatite (PLLA/COL/HA) with or without 
DPSC, polyester poly(isosorbide succinate-co-L-lacti-
de), collagen and hydroxyapatite (PisPLLA/COL/HA) 
with or without DPSC and a control group without treat-
ment. After 4 weeks, PLLA/COL/HA or PisPLLA/COL/
HA scaffolds promoted periodontal regeneration and 
new bone formation. An increased osteoconductive and 
extracellular mineralization capacity were observed for 
the PLLA/COL/HA scaffold, while better osteoinduc-
tive properties were associated to PisPLLA/COL/HA 
scaffold.
Finally, Park et al. (26) in periodontal defects as Cao et 
al. (22), Hu et al. (24) and Khorsand et al. (25) in a dog 
model, evaluated five groups: in one no intervention is 
performed, another to which the defect is created but not 
grafted and the other 3 were filled with autologous stem 
cell graft obtained from immature dog molars: periodon-
tal ligament stem cells (PDLSC), DPSC and periapical fo-
llicle stem cells (PFSC). No scaffold was used to graft all 
the stem cells (26). PDLSC showed the best regeneration 
capacity of PDL, alveolar bone and cementum, as well as 
the innervation and irrigation of the area, which were eva-
luated by conventional and immunological histology, 3D 
micro- computed tomography (CT) and clinically (26).
Discussion
Periodontal tissue engineering uses scaffolds associated 
with biomolecules and differentiable stem cells to form 
suitable supporting tissues. Due to the structural com-
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plexity of the PDL and the morphophysiological diver-
sity of its tissue components, the design of scaffolds for 
periodontal regeneration is highly complex (23). Among 
the analysed studies, Bio-Oss® xenograft (25), PLLA/
COL/HA or PisPLLA/COL/HA (23) are used as sca-
ffolds. The scaffold structure and composition are extre-
mely important in periodontal tissue engineering, since 
it determines the biocompatibility with the host tissues 
and stimulates the regeneration or inhibition of those 
tissues. The scaffold degradation rate should be propor-
tional to the regenerated tissue neoformation because a 
rapid degradation may compromise tissue neoformation, 
whereas slow degradation may promote bone encapsula-
tion or obstruction (23). In spite of this, 3 of the 5 studies 
analysed in this review do not used scaffold (22,24,26).
-Non-use of scaffold
•New bone formation
Cao et al. (22) and Hu et al. (24) with the same minia-
ture pig experimental model, creates periodontal defects 
(three bone walls and a fourth dental wall) that were 
grafted with heterologous cells of human origin. Cao 
et al. (22) obtained significant bone regeneration in all 
the experimental groups compared to the control group 
(p <0.01). The HGF-DPSC sheet obtained the highest 
volume of regenerated bone (69.3 ± 3.9 mm3) and the 
DPSC injection the least (38.2 ± 5.3 mm3) (p <0.01). 
Therefore, it can be concluded that the addition of HGF 
could stimulate the bone formation (22). These results 
are similar to those obtained by Hu et al. (24). The re-
generated alveolar bone volume in the group of DPSC 
sheets was 52.7 ± 4.1 mm3 and in the DPSC injection 
group 32.4 ± 5.1 mm3, data significantly higher than the 
volume of the control group (p <0.05)). In contrast, Park 
et al. (26) using the same study design in a dog model 
obtained almost the same results as in the negative con-
trol group (no stem cells grafted) but the bone height re-
generated was significantly higher in the PDLSC group 
(p <0.0001) than in the DPSC group.
Histomorphometrically, Hu et al. (24) showed a percen-
tage of new bone in the DPSC injection group was signi-
ficantly greater than the control group (p <0.05). There-
fore, the volume of new regenerated bone was higher in 
the DPSC sheet group than in the DPSC injection group 
(p <0.05).
If a scaffold is not used to graft, the therapeutic option 
that has shown the best results in terms of bone rege-
neration, according to the CT, is the HGF-DPSC sheet 
despite the stem cells were from different species.
•New periodontal ligament formation
In Cao et al. study (22) the new Sharpey fibers pene-
trates the regenerated bone tissue in all groups except 
for the DPSC injection and control. Similar results were 
observed by Hu et al. (24), in which there was a new 
union of the Sharpey fibers to the bone and the tooth 
in the experimental groups, unlike the control group in 
which it was very irregular. Park et al. (26) shows that 
the DPSC group failed to regenerate the PDL, whereas 
the PDLSC and the PFSC did.
•New cementum formation
Regarding cementum regeneration, based on CT, Hu et al. 
(24) observed a new layer of cementum-like tissue from 
the alveolar bone height to the amelo-cementum line in 
the experimental groups, which was not appreciated in the 
control group. In the study by Park et al. (26) as well as 
with regeneration of the PDL, the only groups that achie-
ve cementum regeneration were PDLSC and PFSC.
-Bio-Oss® scaffold
•New bone formation
Xenograft scaffold used by Khorsand et al. (25) con-
cluding that there is no significant difference in bone 
formation between the experimental and control group. 
However, the authors concluded that DPSC promote 
periodontal regeneration and claim that the DPSC-Bio-
Oss® biocomplex is excellent (25).
•New periodontal ligament formation
According to a histomorphometric analysis, Khorsand 
et al. (25) obtained a mean value of new periodontal li-
gament of 3.30 ± 1.12 mm and 1.77 ± 1.27 mm for the 
experimental and control group (p <0.05) and conclu-
ded that the PDL is regenerated or not depending not 
only on the DPSC, but also on other factors which are 
unknown. Therefore, in terms of obturation of the defect 
DPSC- xenograft is physically effective, but in terms of 
the tissue quality obtained does not bring benefits with 
respect to the control.
•New cementum formation
According to histomorphometry, in the study by Khor-
sand et al. (25) the new cement formation was signifi-
cantly better comparing to the control group (p <0.05). 
In addition, the regenerated cementum in the experimen-
tal group was thicker and covered a wider root surface 
than in the control group.
-PLLA/COL/HA or PisPLLA/COL/HA scaffold
Although PLLA and PLGA have slower degradation and 
better mechanical properties than collagen membranes, 
these materials have low cellular affinity. Therefore, the 
combination of synthetic and natural polymers, such 
as collagen, is an alternative for tissue engineering as 
it combines the properties of both materials. New co-
polymers containing isosorbide succinate and L-lactide 
promote increased fibroblasts adhesion and proliferation 
and may be a new option to explore (23).
•New bone formation
Best regeneration was seen in the groups in which a 
PLLA or PisPLLA/COL/HA scaffold was grafted wi-
thout DPSC (p <0.05). In the groups in which scaffolds 
were grafted with DPSC the results were similar. There-
fore, Gonçalves et al. (23) state that there is controversy 
in the idea that DPSC benefits cell differentiation and 
promotes bone and periodontal regeneration.
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•New cementum formation
In the study of Gonçalves et al. (23), the only group in 
which the cementum was regenerated with complete 
closure was in PLLA/COL/HA without DPSC. In this 
study, the rat animal model and the defect type are very 
different from the other studies (miniature pigs or dogs), 
and probably this helped to have more favourable rege-
neration. Cao et al. (22) and Hu et al. (24) showed that 
the only groups in which periodontal health was recove-
red were those grafted into sheet  form.
Park et al. (26) consider that autologous PDLSC and 
PFSC transplantation regenerate bone, cementum and 
PDL. PDLSC improved the insertion gain and the re-
generation of periodontal tissue compared to the DPSC 
graft group (p <0.0001).
These results should be approach with caution since the 
origin of the stem cells was human, therefore the DPSC 
are of heterologous origin and the results could be in-
fluenced by an antigenicity component. In this regard, 
the most relevant studies to take into account for future 
studies with humans are the studies by Khorsand et al. 
(25) and Park et al. (26) because they used autologous 
dog DPSC, so that the results are no longer influenced 
by the fact that the stem cells are of a different species 
than the cells of the receptor.
Cao et al. (22) and Hu et al. (23) considered the rege-
neration with the DPSC sheet graft to be more efficient 
and complete than with the dissociated DPSC injection, 
since with the sheet it is possible to regenerate more new 
bone volume, as in the case of Hu et al. (24).
Cell sheets have been widely used and are designed to 
avoid the deficiencies of traditional TE as it has been 
shown to benefit in numerous clinical applications. A 
sheet of cells has a three- dimensional macrostructure 
that mimics the physiological functions of the extrace-
llular matrix, thus eliminating the use of additional ma-
trices or scaffolds. This has the advantage of avoiding 
the strong inflammatory responses that are induced when 
biodegradable matrices are degraded. In this research, 
the new alveolar bone and periodontal soft tissues were 
regenerated to almost normal levels at 12 weeks after 
cell sheets implantation. However, for the grafting of a 
cell sheet, surgery with mucoperiosteal flap elevation is 
required to place it on the defect (22). In contrast, for 
injection only a needle is inserted into the bottom of the 
bone defect (22,24).
There is another study in rabbits, in which they regene-
rate non-periodontal bone defects, combining recombi-
nant human bone morphogenetic protein 2 (rhBMP-2) as 
a grow factor, DPSC and nanohydroxyapatite/collagen/
poly(L-lactide) (nHAC/PLA) scaffold for the seeding, 
proliferation and differentiation of autologous DPSC. 
Therefore, they recommend this treatment as an alterna-
tive to autologous bone grafting for the clinical recons-
truction of bone defects (27). This is another study that 
supports the better work of DPSC plus a trophic factor, 
since it favours cell differentiation.
As far as human studies are concerned, we find two with 
exactly the same analysis than this systematic review: a 
case report (11) and a two case report (13) but in which 
the bone-periodontal defect was secondary to the extrac-
tion of a third molar.
Aimetti et al. (11) presented a human clinical case using 
autologous DPSC for regeneration of a periodontal de-
fect, evaluated with clinical, radiographic and surgical 
re-entry. A 56-year-old with a defect distal to a second 
inferior premolar, with 9 mm probing depth and 3 mm of 
recession, but without mobility. DPSCs they used were 
from a third upper molar that needed to be extracted. 
The dental pulp was collected with a Gracey curette and 
simultaneous mechanical dissociation of the dental pulp 
and filtration of the solution through a 50-micron filter 
was done. After 60 seconds of agitation, the cell suspen-
sion was collected and poured onto a collagen sponge 
matrix, which was placed to completely fill the infra-bo-
ne defect. This treatment got a significant clinical and 
radiological improvement at 6 and 12 months with fi-
lling of the intraosseous component of the defect by a 
bone-like tissue confirmed with surgical reentry. In this 
study, the DPSC are not left in culture for two or three 
weeks to choose the third or fourth passage as do the rest 
of studies, which produces enough cells (21-25). Nor do 
they leave a time period in which the stem cells penetra-
te into the pores of the scaffold (24).
A pilot study with two cases (13) in which they repaired 
human periodontal bone defects with autologous DPSC 
of inflammatory pulp tissue (from teeth with irreversible 
pulpitis). Although these cells have lost some of their 
properties, they maintain some tissue regeneration po-
tential, being able to differentiate into osteogenic cells. 
Considering this pulp as a medical waste, the treatment 
could be more easily accepted by patients than if the 
pulp tissue is extracted from a healthy tooth. These stem 
cells were cultured for 6 days, loaded onto a β-trical-
cium phosphate scaffold and grafted on the periodontal 
defect. After 1, 3 and 9 months, the result was clinically 
and radiologically evaluated. After 9 months the gingi-
val recession, probing depth and bleeding rate slightly 
decreased, and furcation lesions changed from grade III 
to II or I (p<0.05). They conclude that it is a safe proce-
dure and a possible potential treatment to be used in the 
future (13).
Finally, the only clinical trial with a similar theme is the 
study by d’Aquino et al. (15). Its objective was to repair 
an alveolar bone defect, secondary to the extraction of a 
lower third molar, by autologous upper molars DPSC, 
using a collagen sponge scaffold. In these patients, 
a bone and periodontal 2 or 3 walls defect is formed, 
with vertical loss of less than 7 mm distal to the of the 
distal root of the second lower molar. The study has a 
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split-mouth design, so they used one as experimental 
(the collagen sponge was grafted with DPSC) and the 
other as a control (nothing was grafted). Three months 
after surgery, radiological analysis by orthopantomogra-
phy confirmed that the experimental defects were com-
pletely regenerated and that the cortical level was higher 
than at control sites. Regarding the clinical probing dep-
th evaluation revealed an increase in clinical insertion 
greater in the experimental defects than in controls 6,2 
± 2,3 mm and 4,4 ± 1,2 mm (p<0,05). They obtain en-
couraging results and demonstrate that the use of DPSC 
significantly favours bone repair and the collagen resor-
bable scaffold created an efficient and optimal biocom-
plex for bone regeneration. As a limitation, only 17 of 
the 100 patients who started the study were follow- up 
at the end of one year, therefore, the sample size is quite 
small due to the high dropout.
Although several alternatives have been proposed, ideal 
material is not available yet to promote periodontal rege-
neration in an effective, consistent and predictable way 
that can readily be applied clinically. The ideal material 
must comply simultaneously with the principles of gui-
ded tissue regeneration and TE (23).
It coincides with the review on potential stem cell-based 
periodontal therapy by Bassir et al. (8), who propose that 
current evidence indicates that DPSC may not be ideal 
multipotent stem cells for periodontal regeneration, as 
reported by Hynes et al. (4), the results are inconsistent.
According to the review of clinical use of stem cells for 
periodontal regeneration by Hynes et al. (4), the future 
of periodontal regeneration based on stem cells, not only 
with those of the dental pulp, is promising, since animal 
studies have shown that mesenchymal stem cells can be 
used for periodontal regeneration.
The time has come to move from experimental animal 
studies to clinical trials in humans, but first we should 
try to solve some important concepts such as immuno-
genicity, the use of autologous versus allogeneic cells, 
which is the source of more appropriate stem cells, the 
cost-effectiveness of the whole process, both for the 
dentist and for the patient and continue to investigate 
new, easy-to- obtain and low-cost carriers that facilitate 
their use.
Conclusions
Keeping in mind the limitations of this work we can con-
clude that:
- More bone volume is produced and recovery of pe-
riodontal health is achieved when DPSC are grafted in 
form of cell sheets than in dissociated cell injection.
- The addition of trophic factors such as HGF, favours 
the cellular differentiation of DPSC, thus achieving a 
higher amount of regenerated bone, although in none 
of the studies does the stability of the bone gained over 
time.
- The fact that cementum and the PDL are regenerated 
or not depend, not only on the DPSC, but also on other 
unknown factors.
- There are other stem cells of dental origin, such as PD-
LSC that can have better results of periodontal regenera-
tion than the DPSC.
- It is necessary to investigate which growth factors or 
scaffolds can better enhance the capacity of periodontal 
regeneration.
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